Headlands Research Opens Grand Rapids Site Led by Rheumatology Investigator
Headlands Research opens Grand Rapids site led by rheumatology investigator Eric Slavin, expanding clinical trial capacity in the Midwest.
Adaptive Clinical Trial Design Adaptive Trial Design Addiction Psychiatry AI in Clinical Trials Alzheimer's Disease Article Artificial Intelligence in Clinical Trials Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Drug Development CNS Trials Conference Coverage CRO Consolidation Decentralized Clinical Trials Digital Health Technologies eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy FDA Warning Letter GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
Headlands Research opens Grand Rapids site led by rheumatology investigator Eric Slavin, expanding clinical trial capacity in the Midwest.
Velocity Clinical and Stitch expand partnership across 70+ sites, achieving a 9-point reduction in no-show rates and boosting screening...
Phase 3 study shows aQIVc demonstrated superior immunogenicity against influenza strains in adults 50 and older, with responses sustained...
FDA clears Prelude's PRT13722 Phase 1 trial in HR-positive breast cancer, advancing the oral KAT6A degrader toward patient enrollment.
The problem isn't that fewer women get aortic stenosis. It's that the entire pipeline, from diagnosis to device, was...
The FDA approval of etripamil for PSVT occurred in December, 2025. Investigation about a potential role of etripamil in...
TruTechnologies co-founder Rick Graham argues that the industry's real execution problem is not a modeling problem.
Nature Medicine's Validation Accords push for a generative AI consensus framework, and expose a regulatory gap that could invalidate...
PSI CRO presents agile models emerging biotech sponsors can use to scale global trials while maintaining operational control at...
Live site initiation visits should focus on protocol-specific content that creates operational risk, per Christine Senn's framework for SIV...